Collegium Pharmaceutical ... (COLL)
29.69
0.13 (0.44%)
At close: Mar 28, 2025, 3:59 PM
29.00
-2.32%
Pre-market: Mar 31, 2025, 04:21 AM EDT
Collegium Pharmaceutical Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 70.56M | 238.95M | 173.69M | 186.43M | 174.12M | 170.02M | 146.63M | 118.7M | 153.22M | 95.7M | 1.63M | 7.55M |
| Short-Term Investments | 92.2M | 71.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 2.55M | 2.55M | 2.55M | n/a | n/a | 97K | 97K | 97K | n/a | n/a |
| Other Long-Term Assets | 9.41M | 1.87M | 100K | 87K | 2.67M | 178K | 204K | 161K | 301K | n/a | 80K | 80K |
| Receivables | 228.54M | 179.53M | 183.12M | 105.84M | 83.32M | 72.95M | 77.95M | 9.97M | 2.13M | n/a | n/a | n/a |
| Inventory | 35.56M | 32.33M | 46.5M | 17.39M | 15.61M | 9.64M | 7.82M | 1.81M | 1.32M | n/a | n/a | n/a |
| Other Current Assets | 55.39M | 15.2M | 16.68M | 5.88M | 4.84M | 3.1M | 5.12M | 3M | 1.91M | 1.19M | 2.86M | 710K |
| Total Current Assets | 482.26M | 537.6M | 419.99M | 315.54M | 277.89M | 255.72M | 237.51M | 133.48M | 158.57M | 96.88M | 4.5M | 8.26M |
| Property-Plant & Equipment | 20.15M | 22.01M | 26.38M | 27.14M | 27.38M | 20.9M | 9.27M | 1.83M | 1.04M | 738K | 514K | 693K |
| Goodwill & Intangibles | 1.05B | 555.57M | 701.16M | 268.72M | 335.9M | 29.5M | 44.26M | n/a | 2.1M | n/a | n/a | n/a |
| Total Long-Term Assets | 1.18B | 605.71M | 754.14M | 376.53M | 365.95M | 50.58M | 53.73M | 2.08M | 3.44M | 835K | 594K | 773K |
| Total Assets | 1.66B | 1.14B | 1.17B | 692.08M | 643.84M | 306.3M | 291.25M | 135.57M | 162.02M | 97.72M | 5.09M | 9.03M |
| Account Payables | 3.93M | 8.69M | 3.49M | 4.19M | 10.02M | 6.25M | 12.15M | 5.68M | 9.11M | 3.54M | 2.21M | 1.22M |
| Deferred Revenue | 10M | 988K | n/a | n/a | n/a | n/a | n/a | n/a | 4.94M | -9.55M | n/a | n/a |
| Short-Term Debt | 65.85M | 184.32M | 164.72M | 49.98M | 48.95M | 5.14M | 1.64M | 1.48M | 2.67M | 2.67M | 6.19M | 333K |
| Other Current Liabilities | 414.54M | 256.76M | 261.16M | 222.2M | 178.66M | 190.37M | 175.33M | 24.32M | 8.88M | 2.23M | 2.02M | 1.07M |
| Total Current Liabilities | 509.51M | 457.92M | 270.11M | 230.4M | 191.23M | 197.28M | 187.48M | 31.49M | 22.93M | 5.76M | 10.42M | 2.62M |
| Long-Term Debt | 793.44M | 489.96M | 545.56M | 209.58M | 218.36M | 17.11M | 9.86M | n/a | 1.51M | 4.21M | 6.91M | 775K |
| Other Long-Term Liabilities | 131.79M | n/a | n/a | n/a | n/a | n/a | 676K | n/a | n/a | n/a | n/a | 59K |
| Total Long-Term Liabilities | 925.24M | 489.96M | 709.17M | 258.75M | 266.58M | 21.59M | 12.18M | 7.16M | 4.18M | 6.88M | 6.91M | 834K |
| Total Liabilities | 1.43B | 947.88M | 979.29M | 489.15M | 457.81M | 218.87M | 199.66M | 31.49M | 27.11M | 12.65M | 17.33M | 3.45M |
| Total Debt | 859.3M | 674.28M | 872.79M | 258.75M | 266.58M | 21.59M | 11.5M | 1.48M | 4.15M | 6.81M | 13.01M | 973K |
| Common Stock | 40K | 38K | 37K | 36K | 35K | 34K | 33K | 33K | 29K | 21K | 8K | 1K |
| Retained Earnings | -164M | -233.19M | -281.34M | -256.34M | -333.15M | -359.9M | -337.18M | -298.05M | -223.18M | -129.01M | -101.75M | -80.54M |
| Comprehensive Income | 55K | 14K | 0.00 | -0.00 | -0.00 | n/a | n/a | -1.67M | -1.33M | -1.07M | -903K | -716K |
| Shareholders Equity | 228.84M | 195.43M | 194.84M | 202.93M | 186.03M | 87.43M | 91.58M | 104.08M | 134.91M | 85.07M | -12.24M | 5.58M |
| Total Investments | 92.2M | 71.6M | 2.55M | 2.55M | 2.55M | n/a | n/a | 97K | 97K | 97K | n/a | n/a |